503
Views
3
CrossRef citations to date
0
Altmetric
Letters to the Editor

Managing the combination of non-alcoholic fatty liver disease and metabolic syndrome

, , & , MD FCP FFPM FRCP FRCPath
Pages 287-288 | Published online: 13 Jan 2012

Bibliography

  • Moscatiello S, Di Luzio R, Sasdelli AS, Managing the combination of non-alcoholic fatty liver disease and metabolic syndrome. Expert Opin Pharmacother 2011;12:2657-72
  • Alberti KG, Eckel RH, Grundy SM, Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-5
  • Athyros VG, Ganotakis ES, Tziomalos K, Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population. Curr Med Res Opin 2010;26:713-19
  • Katsiki N, Athyros VG, Karagiannis A, Hyperuricaemia and Non-Alcoholic Fatty Liver Disease (NAFLD): a Relationship with Implications for Vascular Risk? Curr Vasc Pharmacol 2011;9:698-705
  • Targher G, Chonchol M, Zoppini G, Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link? J Hepatol 2011;54:1020-9
  • Athyros VG, Tziomalos K, Daskalopoulos GN, Statin-based treatment for cardiovascular risk and non-alcoholic fatty liver disease. Killing two birds with one stone? Ann Med 2011;43:167-71
  • Swislocki AL, Siegel D, Jialal I. Pharmacotherapy for the Metabolic Syndrome. Curr Vasc Pharmacol 2011; Epub ahead of print
  • Athyros VG, Tziomalos K, Gossios TD, GREACE Study Collaborative Group. Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis. Lancet 2010;376:1916-22
  • Athyros VG, Mikhailidis DP, Liberopoulos EN, Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study. Nephrol Dial Transplant 2007;22:118-27

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.